Treatment of cystinosis with delayed-release cysteamine: 6-year follow-up

Pediatric Nephrology

Volumn 28, Issue 3, 2013, Pages 507-510

  Dohil, Ranjan ^a   Cabrera, Betty L ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE; MERCAPTAMINE;

ABDOMINAL PAIN; ADULT; ANAPHYLACTOID PURPURA; ARTICLE; CASE REPORT; CYSTINOSIS; DELAYED RELEASE FORMULATION; DRUG DOSE TITRATION; DRUG WITHDRAWAL; EXON; FEMALE; FOLLOW UP; GENOTYPE; HALITOSIS; HUMAN; HYPERTENSION; KIDNEY TRANSPLANTATION; LEUKOCYTE; MALE; NOCTURNAL ENURESIS; NONSENSE MUTATION; PLASMAPHERESIS; PRIORITY JOURNAL; SIDE EFFECT; STEROID THERAPY; WEIGHT GAIN;

ADOLESCENT; BIOLOGICAL MARKERS; CHEMISTRY, PHARMACEUTICAL; CREATININE; CYSTEAMINE; CYSTINOSIS; DELAYED-ACTION PREPARATIONS; DRUG ADMINISTRATION SCHEDULE; FANCONI SYNDROME; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; LEUKOCYTE COUNT; MALE; NEPHROTIC SYNDROME; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84876293232     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-012-2315-5     Document Type: Article

References (18)

1. Gahl WA, Thoene JG, Schneider JA (2002) Cystinosis. N Engl J Med 347:111-121
2. Levtchenko EN, van Dael CM, de Graaf-Hess AC, Wilmer MJ, van den Heuvel LP, Monnens LA, Blom HJ (2006) Strict cysteamine dose regimen is required to prevent nocturnal cystine accumulation in cystinosis. Pediatr Nephrol 21:110-113
3. Gahl WA, Reed GF, Thoene JG, Schulman JD, Rizzo WB, Jonas AJ, Denman DW, Schesselman JJ, Corden BJ, Schneider JA (1987) Cysteamine therapy for children with nephropathic cystinosis. N Engl J Med 316:971-977
4. Markello TC, Bernardini IM, Gahl WA (1993) Improved renal function in children with cystinosis treated with cysteamine. N Engl J Med 328:1157-1162
5. Kleta R, Bernardini I, Ueda M, Varade WS, Phornphutkul C, Krasnewich D, Gahl WA (2004) Long-term follow-up of well-treated nephropathic cystinosis patients. J Pediatr 145:555-560
6. Elenberg E, Norling LL, Kleinman RE, Ingelfinger JR (1998) Feeding problems in cystinosis. Pediatr Nephrol 12:365-370
7. Dohil R, Newbury RO, Sellers ZM, Deutsch R, Schneider JA (2003) The evaluation and treatment of gastrointestinal disease in children with cystinosis receiving cysteamine. J Pediatr 143:224-230
8. Schneider JA (2004) Treatment of cystinosis: simple in principle, difficult in practice. J Pediatr 145:436-438
9. Sonies BC, Almajid P, Kleta R, Bernardini I, Gahl WA (2005) Swallowing dysfunction in 101 patients with nephropathic cystinosis: benefit of long-term cysteamine therapy. Med (Baltimore) 84:137-146
10. Dohil R, Fidler M, Barshop BA, Newbury RO, Sellers ZM, Deutsch R, Schneider JA (2006) Understanding intestinal cysteamine bitartrate absorption. J Pediatr 148:764-769
11. Dohil R, Fidler M, Gangoiti JA, Kaskel F, Schneider JA, Barshop BA (2010) Twice-daily cysteamine bitartrate therapy for children with cystinosis. J Pediatr 156:71-75
12. Dohil R, Gangoiti JA, Cabrera BL, Fidler M, Schneider JA, Barshop BA (2010) Long-term treatment of cystinosis in children with twice-daily cysteamine. J Pediatr 156:823-827
13. Schwartz GJ, Munoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629-637
14. Guan X, Hoffman G, Dwivedi C, Matthees DP (2003) A simultaneous liquid chromatography/mass spectrometric assay of glutathione, cysteine, homecysteine and their disulfides in biological samples. J Pharm Biomed Anal 31:251-261
15. Shotelersuk V, Larson D, Anikster Y, McDowell G, Lemons R, Bernardini I, Guo J, Thoene J, Gahl WA (1998) CTNS mutations in an American-based population of cystinosis patients. Am J Hum Genet 63:1352-1362
16. Langman CB, Greenbaum LA, Sarwar M, Grimm P, Niaudet P, Deschenes G, Cornelissen E, Morin D, Cochat P, Matossian D, Gaillard S, Bagger MJ, Rioux P (2012) A randomized controlled crossover trial with RP103 for nephropathic cystinosis. Clin J Am Soc Nephrol 7:112-120
17. Besouw M, Blom H, Tangerman A, de Graaf-Hess A, Levtchenko E (2007) The origin of halitosis in cystinotic patients due to cysteamine treatment. Mol Genet Metab 91:228-233
18. Besouw M, Tangerman A, Cornelissen E, Rioux P, Levtchenko E (2012) Halitosis in cystinosis patients after administration of immediate-release cysteamine bitartrate compared to delayed-release cysteamine bitartrate. Mol Genet Metab. doi: 10.1016/j.ymgme.2012.06.017